Hiroshi Koga

3.3k total citations
106 papers, 1.7k citations indexed

About

Hiroshi Koga is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, Hiroshi Koga has authored 106 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pathology and Forensic Medicine, 60 papers in Genetics and 51 papers in Rheumatology. Recurrent topics in Hiroshi Koga's work include Autoimmune Bullous Skin Diseases (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (59 papers) and Urticaria and Related Conditions (50 papers). Hiroshi Koga is often cited by papers focused on Autoimmune Bullous Skin Diseases (81 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (59 papers) and Urticaria and Related Conditions (50 papers). Hiroshi Koga collaborates with scholars based in Japan, Germany and India. Hiroshi Koga's co-authors include Takashi Hashimoto, Norito Ishii, Daisuke Tsuruta, Chika Ohata, Bungo Ohyama, Kwesi Teye, Takekuni Nakama, Teruki Dainichi, Katja Bieber and Tadashi Karashima and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroshi Koga

97 papers receiving 1.7k citations

Peers

Hiroshi Koga
Yu Oyama United States
Juehua Gao United States
Qin Huang United States
Galina S. Bogatkevich United States
Hiroshi Koga
Citations per year, relative to Hiroshi Koga Hiroshi Koga (= 1×) peers Alessandra Marrelli

Countries citing papers authored by Hiroshi Koga

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Koga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Koga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Koga more than expected).

Fields of papers citing papers by Hiroshi Koga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Koga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Koga. The network helps show where Hiroshi Koga may publish in the future.

Co-authorship network of co-authors of Hiroshi Koga

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Koga. A scholar is included among the top collaborators of Hiroshi Koga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Koga. Hiroshi Koga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koga, Hiroshi, et al.. (2024). A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation. The Journal of Dermatology. 51(7). e231–e232.
2.
Takeichi, Takuya, Takahiro Hamada, Mayuko Yamamoto, et al.. (2023). Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes. The Journal of Dermatology. 51(1). 101–105. 2 indexed citations
3.
Miyachi, Hideaki, Hiroshi Koga, Norito Ishii, et al.. (2023). Simultaneous development of generalized pustular psoriasis and pemphigoid with multiple autoantibodies in a complete responder of pembrolizumab for lung cancer. The Journal of Dermatology. 50(10). 1343–1346. 3 indexed citations
4.
Matsuda, Mitsuhiro, Hiroshi Koga, Chika Ohata, et al.. (2022). Anti‐desmoglein 1 antibody‐positive mother and antibody‐negative child with Darier's disease. The Journal of Dermatology. 50(2). 250–253.
5.
Koga, Hiroshi, Masahiro Tsutsumi, Kwesi Teye, et al.. (2022). Subcorneal pustular dermatosis‐type IgA pemphigus associated with multiple myeloma: A case report and literature review. The Journal of Dermatology. 50(2). 234–238. 4 indexed citations
6.
Hamada, Takahiro, et al.. (2022). Dermoscopic furrow ink test of the palmar lesion in loricrin keratoderma. The Journal of Dermatology. 49(8). 783–786.
7.
Endo, Yuki, Sadamu Toki, Akira Oka, et al.. (2022). Pemphigus vegetans with antibodies against desmoglein 1 and desmocollin 1–3: a case report and literature review. Journal of the European Academy of Dermatology and Venereology. 36(12). e998–e1000. 2 indexed citations
8.
Dainichi, Teruki, Yo Kaku, Norito Ishii, et al.. (2021). Dipeptidyl peptidase 4 inhibitor‐associated mucous membrane pemphigoid. The Journal of Dermatology. 48(10). 1584–1587. 5 indexed citations
9.
Iwata, Hiroaki, Yosuke Mai, Keisuke Imafuku, et al.. (2021). Super‐resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid. The Journal of Dermatology. 49(3). 374–378. 8 indexed citations
10.
Shiraishi, Ken, et al.. (2021). Case of pemphigoid vegetans with autoantibodies against the BP180 C‐terminal domain and BP230 antigen. The Journal of Dermatology. 48(8). 1286–1290. 4 indexed citations
11.
Yokoyama, Emi, Osamu Yamasaki, Toshio Kubo, et al.. (2021). A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer. Journal of Cutaneous Immunology and Allergy. 4(6). 170–172. 1 indexed citations
12.
Yoshida, Satoshi, Ken Shiraishi, Hideki Mori, et al.. (2021). Lichen planus pemphigoides with antibodies against the BP180 C‐terminal domain induced by pembrolizumab in a melanoma patient. The Journal of Dermatology. 48(9). e449–e451. 5 indexed citations
13.
Koga, Hiroshi, et al.. (2021). Autoantibodies to DSC3 in Pemphigus Exclusively Recognize Calcium-Dependent Epitope in Extracellular Domain 2. Journal of Investigative Dermatology. 141(9). 2123–2131.e2. 5 indexed citations
14.
Koga, Hiroshi, et al.. (2020). Lichen planus‐like lesion preceding bullous pemphigoid development after programmed cell death protein‐1 inhibitor treatment. The Journal of Dermatology. 48(3). 401–404. 11 indexed citations
15.
Koga, Hiroshi, Kwesi Teye, Norito Ishii, & Takekuni Nakama. (2019). Detachment of keratinocytes at the basement membrane zone caused by inhibitory effect of the antibodies from sera of mucous membrane pemphigoid patients. The Journal of Dermatology. 46(11). 1046–1048. 1 indexed citations
16.
Koga, Hiroshi, Kwesi Teye, Kohei Yamashita, et al.. (2018). Detection of anti‐type VII collagen IgE antibodies in epidermolysis bullosa acquisita. British Journal of Dermatology. 180(5). 1107–1113. 6 indexed citations
17.
Bieber, Katja, Hiroshi Koga, & Wataru Nishie. (2017). In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases. Experimental Dermatology. 26(12). 1163–1170. 38 indexed citations
18.
Kanwar, Amrinder J., Keshavamurthy Vinay, Gitesh U. Sawatkar, et al.. (2014). Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study. British Journal of Dermatology. 170(6). 1341–1349. 58 indexed citations
19.
Tsuchisaka, Atsunari, Hideo Kawano, Atsushi Yasukochi, et al.. (2014). Immunological and Statistical Studies of Anti-BP180 Antibodies in Paraneoplastic Pemphigus. Journal of Investigative Dermatology. 134(8). 2283–2287. 15 indexed citations
20.
Dainichi, Teruki, Sadamu Kurono, Bungo Ohyama, et al.. (2009). Anti-laminin gamma-1 pemphigoid. Proceedings of the National Academy of Sciences. 106(8). 2800–2805. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026